Apoptosis, also known as programmed cell death, is a fundamental biological process crucial for maintaining cellular homeostasis and eliminating damaged or unwanted cells. It is a highly regulated and orchestrated mechanism that occurs naturally during development, tissue maintenance, and the immune response. Apoptosis is characterized by distinct morphological and biochemical changes in cells, including cell shrinkage, membrane blebbing, chromatin condensation, and the formation of apoptotic bodies. These changes facilitate the efficient removal of cells without inducing inflammation, preserving tissue integrity. The process of apoptosis is controlled by a complex interplay of signaling pathways, involving various regulatory proteins and enzymes. Key players include caspases, which are proteases that mediate the dismantling of cellular components. Apoptosis can be triggered by intrinsic factors, such as DNA damage or cellular stress, or extrinsic signals, like death ligands binding to cell surface receptors. Apoptosis is critical in embryonic development for shaping tissues and organs by eliminating surplus cells. In adults, it serves to maintain tissue homeostasis, regulate the immune system, and eliminate cells with irreparable damage or infections. Dysregulation of apoptosis is implicated in various diseases, including cancer, neurodegenerative disorders, and autoimmune conditions. Understanding apoptosis has significant implications for medical research and therapeutic interventions. Targeting apoptotic pathways is explored for cancer treatment, while modulating apoptosis is considered in neuroprotection and tissue regeneration strategies. The study of apoptosis continues to uncover insights into cellular biology and provides avenues for developing novel therapeutic approaches.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Will be updated soon...
Vasiliki E Kalodimou, European University-Cyprus Ltd, Cyprus
Title : Will be updated soon...
Nagy Habib, Imperial College London, United Kingdom
Title : Will be updated soon...
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : Advanced 3D tissue models: Pioneering tools for investigating health and disease
Lucie Bacakova, Institute of Physiology of the Czech Academy of Sciences, Czech Republic
Title : Developing iPSC-derived 3D Outer Blood-Retinal Barrier Disease Models of Choroideremia for Gene Therapy Evaluation
Aradhana Kasimsetty, National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH), United States